AssayIndex
Contributing laboratory

Janoshik Analytical

The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. 3,159 reports in the index — 47.0 % of the total.

3,159 reportsgradient 30 minHigh-resolution MSrepeatability 0.18 pp
Section 1

Identification and method basis

Laboratory
Janoshik Analytical
Short code in this index
Janoshik
Location
Ostrava, Czechia
Founded
2018
Reports contributed
3,159
Share of index
47.0%
Purity gradient
30min
Mass resolution
High resolution (ESI-TOF / QTOF)
Stated turnaround
3–6 business days
Measured offset vs reference
0.000 — reference
Within-lab repeatability
0.18pp

Janoshik contributes just under half of all reports in the index and is the reference laboratory for the index's inter-lab bias estimates. That choice is pragmatic rather than a quality judgement: with the largest number of paired comparisons available, using Janoshik as the zero point produces the tightest confidence intervals on the other five labs' offsets. It does not mean Janoshik is correct in an absolute sense, and the index says so wherever a bias figure appears.

Methodologically, Janoshik runs a 30-minute reverse-phase gradient that is close enough to the index reference method RG-2 that no gradient-length correction is applied to its results. Identity is confirmed by high-resolution ESI-TOF, which means the 1 Da bremelanotide/melanotan II distinction and the 14 Da hexarelin/GHRP-6 distinction are both within its capability — a claim only three of the six labs here can make.

Two limitations recur in the index's Janoshik record set. Endotoxin and sterility are offered but ordered on a minority of submissions, so those columns are sparse. And where a submitter orders purity alone, the resulting record cannot support an identity claim, which is why 18 % of Janoshik-sourced records in the index carry the status "purity only — identity not established".

Section 2

Methods offered

What a laboratory can measure decides what a record can establish. A submission that orders only purity produces a record that names nothing.

  • RP-HPLC purity (%area, 214 nm)
  • LC-MS identity (ESI-TOF, high resolution)
  • peptide content by HPLC against a certified standard
  • Karl Fischer water (coulometric)
  • counter-ion by ion chromatography
  • endotoxin by kinetic chromogenic LAL
  • sterility by membrane filtration, USP <71>
Section 3

What this laboratory has measured

Reports 3,159
Median purity reported 99.01% n=3151
Index median 98.99% n=6722
Batches touched 973
015130245392.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=395.75–96.00 %: n=196.00–96.25 %: n=696.25–96.50 %: n=796.50–96.75 %: n=1596.75–97.00 %: n=2397.00–97.25 %: n=3297.25–97.50 %: n=6797.50–97.75 %: n=10197.75–98.00 %: n=15598.00–98.25 %: n=24298.25–98.50 %: n=28898.50–98.75 %: n=31598.75–99.00 %: n=30299.00–99.25 %: n=36899.25–99.50 %: n=35799.50–99.75 %: n=33299.75–100.00 %: n=537median 99.01 Purity (% area) Reports
Figure 1. Distribution of purity figures reported by Janoshik. This is not a distribution of material quality — it is a distribution of what this laboratory was sent, which is a different and unrepresentative sample. Compare its shape against another laboratory's rather than its position: a short gradient compresses the left tail because unresolved species are counted into the main peak.
Most-tested compounds hereReportsMedian purity
Semaglutide40498.87
BPC-15727799.13
Tirzepatide27198.39
Retatrutide21298.51
TB-50017899.53
Ipamorelin10899.54
GHRP-610899.70
PT-141 (Bremelanotide)9499.22
Melanotan II8999.31
Liraglutide7298.74
MK-677 (Ibutamoren mesylate)7099.41
Semax6799.34
CJC-1295 with DAC6498.78
CJC-1295 (no DAC)6098.62
L-Glutathione (reduced)5999.07
Selank5899.09
Section 4

Agreement with the other laboratories

Each row is a paired analysis: batches where this laboratory and another one both assayed the same physical lot. A difference on a matched pair is bias plus noise, and it is the only clean way to compare laboratories.

AgainstPaired lotsMean difference (pp)95 % limits of agreementWithin 0.5 pp
PeptideMeter569+0.024-0.65 to 0.7086%
Medutest517-0.065-0.87 to 0.7479%
VendorInvestigate380+0.493-0.29 to 1.2751%
Nordanalyt357+0.005-0.71 to 0.7284%
Kestrel296-0.382-1.37 to 0.6161%

Positive means Janoshik read higher. The full paired analysis, with its assumptions →

Section 5

Provenance of what this laboratory receives

A laboratory that mostly receives supplier-supplied samples produces a record set with a known upward pressure on it, however good its analysis is. This is a property of the submission channel and not of the laboratory.

ProvenanceReportsShareEvidentiary weight
Buyer-sourced2307.3%Strongest available evidence in this index.
Supplier-supplied272786.3%Weaker evidence. Read with the caveat below.
Laboratory-retained2026.4%Provenance documented, selection uncontrolled.
Section 6

Recent records from this laboratory

The 25 most recent of 3,159. All records from Janoshik →
ReportCompoundSupplierLotQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042737SelankGGPepsGGPE-2603-J97082026-Q398.409.1497.4Buyer-sourced0FAIL
AX-2026-042461Kisspeptin-10SWBSWB-2603-D62382026-Q398.354.6596.5Supplier-supplied3FAIL
AX-2026-041683CJC-1295 (no DAC)QSCQSC-2606-V86372026-Q399.933.6397.1Supplier-supplied1FAIL
AX-2026-042804SelankGGPepsGGPE-2602-G20562026-Q398.507.97Supplier-supplied0FAIL
AX-2026-041727CJC-1295 with DACQSCQSC-2602-E94742026-Q398.886.62105.3Supplier-supplied1MARGINAL
AX-2026-041387BPC-157WWBWWB-2606-H39062026-Q398.954.64Laboratory-retained1MARGINAL
AX-2026-041334SemaglutideWWBWWB-2606-N31922026-Q398.835.04Supplier-supplied1MARGINAL
AX-2026-041932SemaglutideTFCTFC-2604-X43012026-Q398.884.31Supplier-supplied0PASS
AX-2026-042803SelankGGPepsGGPE-2602-G20562026-Q398.488.01Laboratory-retained1FAIL
AX-2026-043335LiraglutideCPCCPC-2602-G19782026-Q397.294.91Laboratory-retained1FAIL
AX-2026-042802SelankGGPepsGGPE-2602-G20562026-Q398.747.0996.0Supplier-supplied0FAIL
AX-2026-043574N-Acetyl Semax AmideBCHBCH-2602-E82532026-Q397.758.8597.9Supplier-supplied1FAIL
AX-2026-042796SelankGGPepsGGPE-2602-G20562026-Q398.267.5697.5Buyer-sourced0FAIL
AX-2026-041742TirzepatideFGPFGP-2603-L97142026-Q399.372.43105.5Supplier-supplied1MARGINAL
AX-2026-042648Melanotan IIGGPepsGGPE-2603-P87352026-Q399.106.97Supplier-supplied4MARGINAL
AX-2026-042535TesamorelinERPERP-2604-W72802026-Q399.193.8992.7Supplier-supplied1MARGINAL
AX-2026-042181IpamorelinHomopeptideHOMO-2608-A90452026-Q399.784.79Supplier-supplied1MARGINAL
AX-2026-042172SemaglutideHomopeptideHOMO-2604-X89212026-Q399.645.1691.9Supplier-supplied1MARGINAL
AX-2026-042180IpamorelinHomopeptideHOMO-2608-A90452026-Q399.394.74105.5Supplier-supplied1MARGINAL
AX-2026-043332LiraglutideCPCCPC-2602-G19782026-Q397.164.8891.3Supplier-supplied1FAIL
AX-2026-043180Kisspeptin-10GL BiochemGLBI-2608-N80852026-Q398.693.37103.8Supplier-supplied2MARGINAL
AX-2026-042577TB-500ERPERP-2605-S80222026-Q399.513.45Supplier-supplied1MARGINAL
AX-2026-041454RetatrutideQYBQYB-2604-B56602026-Q398.842.77Supplier-supplied1MARGINAL
AX-2026-042479Melanotan IISWBSWB-2603-A57072026-Q399.163.6794.5Supplier-supplied1MARGINAL
AX-2026-041456RetatrutideQYBQYB-2604-B56602026-Q398.233.24Supplier-supplied1MARGINAL